NYSEArca - Delayed Quote USD

VanEck China Growth Leaders ETF (GLCN)

21.08 -0.09 (-0.41%)
At close: September 20 at 1:21 PM EDT
Key Events
Loading Chart for GLCN
DELL
  • Previous Close 21.36
  • Open 21.08
  • Bid 8.46 x 1000
  • Ask --
  • Day's Range 21.08 - 21.08
  • 52 Week Range 21.08 - 29.39
  • Volume 1,262
  • Avg. Volume 675
  • Net Assets 12.19M
  • NAV 21.24
  • PE Ratio (TTM) 7.99
  • Yield 2.59%
  • YTD Daily Total Return -13.70%
  • Beta (5Y Monthly) 0.67
  • Expense Ratio (net) 0.60%

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index and/or in investments that have economic characteristics that are substantially identical to the economic characteristics of the securities that comprise its benchmark index. The index is comprised of Chinese equity securities which are generally considered by the index provider to exhibit favorable fundamental characteristics according to its proprietary scoring methodology.

VanEck

Fund Family

China Region

Fund Category

12.19M

Net Assets

2010-10-13

Inception Date

Performance Overview: GLCN

Trailing returns as of 10/3/2023. Category is China Region.

YTD Return

GLCN
13.70%
Category
3.05%
 

1-Year Return

GLCN
9.40%
Category
18.48%
 

3-Year Return

GLCN
17.41%
Category
17.29%
 

Holdings: GLCN

Top 10 Holdings (40.64% of Total Assets)

SymbolCompany% Assets
00857
00857 8.39%
0700.HK
Tencent Holdings Limited 6.09%
000858.SZ
Wuliangye Yibin Co.,Ltd. 4.97%
000568.SZ
Luzhou Laojiao Co.,Ltd 4.27%
603259.SS
WuXi AppTec Co., Ltd. 4.00%
300760.SZ
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. 3.16%
300122.SZ
Chongqing Zhifei Biological Products Co., Ltd. 2.74%
600809.SS
Shanxi Xinghuacun Fen Wine Factory Co.,Ltd. 2.61%
002460.SZ
Ganfeng Lithium Group Co., Ltd. 2.30%
2331.HK
Li Ning Company Limited 2.10%

Sector Weightings

SectorGLCN
Healthcare   17.47%
Energy   13.12%
Technology   10.34%
Industrials   7.84%
Real Estate   1.31%
Utilities   0.16%

Recent News: GLCN

VanEck Announces Changes to ETF Product Line

VanEck Announces Changes to ETF Product Line

Research Reports: GLCN

  • SCVL: Rating decreased to a HOLD

    SHOE CARNIVAL INC has an Investment Rating of HOLD; a target price of $23.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     
  • SCVL: Raising target price to $26.00

    SHOE CARNIVAL INC has an Investment Rating of BUY; a target price of $26.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • CHRS: What does Argus have to say about CHRS?

    COHERUS BIOSCIENCES INC has an Investment Rating of SELL; a target price of $4.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.

    Rating
    Price Target
     
  • CHRS: What does Argus have to say about CHRS?

    COHERUS BIOSCIENCES INC has an Investment Rating of SELL; a target price of $4.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.

    Rating
    Price Target
     

Related Tickers